CAS: 929095-18-1 - GSK-461364
Formel:C27H28F3N5O2S
InChl:InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1
InChI Key:InChIKey=ZHJGWYRLJUCMRT-QGZVFWFLSA-N
SMILES:O=C(N)C=1SC(=CC1OC(C=2C=CC=CC2C(F)(F)F)C)N3C=NC=4C=CC(=CC43)CN5CCN(C)CC5
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | GSK461364 REF: TM-T6282CAS: 929095-18-1 | 99.5% | 37,00 €~1.189,00 € | Di 04 Jun 24 |
 | GSK 461364 REF: TR-G797705CAS: 929095-18-1 | - - - | 93,00 €~152,00 € | Mo 08 Jul 24 |
 | GSK 461364 REF: 3D-FM43315CAS: 929095-18-1 | Min. 95% | Nachfragen | Di 09 Jul 24 |
GSK461364
CAS:929095-18-1
GSK461364 (GSK461364A)(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than …
Formel:
C27H28F3N5O2S
Reinheit:
99.5%
Farbe und Form:
Solid
Molekulargewicht:
543.6
Ref: TM-T6282
| 1mg | 37,00 € | |
| 2mg | 52,00 € | |
| 5mg | 73,00 € | |
| 10mg | 121,00 € | |
| 25mg | 202,00 € | |
| 50mg | 365,00 € | |
| 100mg | 549,00 € | |
| 200mg | 779,00 € | |
| 500mg | 1.189,00 € | |
| 1ml*10 (DMSO) | 88,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 4. Juni 2024
GSK 461364
CAS:929095-18-1
Applications GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as …
Formel:
C27H28F3N5O2S
Farbe und Form:
Neat
Molekulargewicht:
543.6
Ref: TR-G797705
| 5mg | 152,00 € | |
| 2500µg | 93,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 8. Juli 2024
GSK 461364
CAS:929095-18-1
A selective ATP-competitive inhibitor of polo-like kinase 1 (Plk1). This protein is a serine/threonine kinase …
Formel:
C27H28F3N5O2S
Reinheit:
Min. 95%
Molekulargewicht:
543.6 g/mol
Ref: 3D-FM43315
| 10mg | Nachfragen | |
| 50mg | Nachfragen | |
| 100mg | Nachfragen | |
| 250mg | Nachfragen | |
| 500mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 9. Juli 2024
